Aphasia Clinical Trials
2 recruiting trials for Aphasia. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Aphasia clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Second Affiliated Hospital, School of Medicine, Zhejiang University (1), University Hospital, Toulouse (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Intraoperative high-density ECoG recording (procedure, 1 trial), followed by Permanent high-density ECoG implantation, Semantic rehabilitation.
Track Aphasia trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Chinese-Specific Speech Imagery Coding Using High-Density ECoG
The goal of this study is to investigate whether high-density electrocorticography (ECoG) signals recorded from the surface of the brain can be used to decode neural...
Effect of Anomia Rehabilitation Combined With Metacognitive Training in Patients With Chronic Vascular Aphasia
The postulate of this study is that rehabilitation combining linguistic and metacognitive training will result in a significant improvement in language performance correlated with...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Aphasia, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Aphasia, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Aphasia, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.